Atlas FDA

CraniSeal Dural Sealant

FDA premarket approval P220014 · decided 2023-07-06

Approval details

PMA number
P220014
Trade name
CraniSeal Dural Sealant
Generic name
Sealant, dural
Applicant
Pramand, LLC
Date received
2022-09-02
Decision date
2023-07-06
Days to decision
307 days
Decision code
APPR
Product code
NQR
Advisory committee
Neurology
Expedited review
No
Location
Bedford, MA
Statement
Approval for the CraniSeal Dural Sealant. The device is indicated for use in patients >= 18 years of age as an adjunct to sutured dural repair during cranial surgery to provide watertight closure.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.